Hypothalamo-pituitary-adrenal function in pituitary adenoma and craniopharyngioma. Part II: insulin test and clinical features.
For the assessment of hypothalamic corticotropin releasing hormone (CRH) secretory function, insulin test, lysinevasopressin test, and rapid ACTH test were performed and plasma crotisol was assayed. Disturbances of CRH secretory activities were found not to be related with the degree of suprasellar extension of tumors, contents of tumors, the degree of visual disturbances, or the duration of symptoms, and it was supposed that more complex mechanisms were responsible for CRH secretory abnormalities.
D000238:Adenoma, Chromophobe / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D003397:Craniopharyngioma / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology*; D003560:Cysts / Q000473:pathology; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D007328:Insulin; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology*; D010913:Pituitary-Adrenal System / Q000503:physiopathology*; D013997:Time Factors; D014786:Vision Disorders / Q000150:complications; D014794:Visual Fields
D007328:Insulin; D003346:Corticotropin-Releasing Hormone